Expression of the p210BCR-ABL oncoprotein drives centrosomal hypertrophy and clonal evolution in human U937 cells (original) (raw)

• Sawyers CL . Chronic myeloid leukemia. N Engl J Med 1999; 340: 1330–1340.
  Article CAS Google Scholar
• Barnes DJ, Melo JV . Cytogenetic and molecular genetic aspects of chronic myeloid leukaemia. Acta Haematol 2002; 108: 180–202.
  Article CAS Google Scholar
• Calabretta B, Perrotti D . The biology of CML blast crisis. Blood 2004; 103: 4010–4022.
  Article CAS Google Scholar
• Hochhaus A, Weisser A, La Rosée P, Emig M, Müller MC, Saussele S et al. Detection and quantification of residual disease in chronic myelogenous leukemia. Leukemia 2000; 14: 998–1005.
  Article CAS Google Scholar
• Müller MC, Gattermann N, Lahaye T, Deininger MW, Berndt A, Fruehauf S et al. Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon alpha/ara-C. Leukemia 2003; 17: 2392–2400.
  Article Google Scholar
• Patel H, Marley SB, Gordon MY . Detection in primary chronic myeloid leukaemia cells of p210BCR-ABL1 in complexes with adaptor proteins CBL, CRKL, and GRB2. Genes Chromosomes Cancer 2006; 45: 1121–1129.
  Article CAS Google Scholar
• Johansson B, Fioretos T, Mitelman F . Cytogenetic and molecular genetic evolution of chronic myeloid leukemia. Acta Haematol 2002; 107: 76–94.
  Article CAS Google Scholar
• Babicka L, Zemanova Z, Pavlistova L, Brezinova J, Ransdorfova S, Houskova L et al. Complex chromosomal rearrangements in patients with chronic myeloid leukemia. Cancer Genet Cytogenet 2006; 168: 22–29.
  Article CAS Google Scholar
• Marx J . Cell biology. Do centrosome abnormalities lead to cancer? Science 2001; 292: 426–429.
  Article CAS Google Scholar
• Hahn WC, Weinberg RA . Rules for making human tumor cells. N Engl J Med 2002; 347: 1593–1603.
  Article CAS Google Scholar
• Pihan GA, Wallace J, Zhou Y, Doxsey SJ . Centrosome abnormalities and chromosome instability occur together in pre-invasive carcinomas. Cancer Res 2003; 63: 1398–1404.
  CAS PubMed Google Scholar
• Pihan GA, Purohit A, Wallace J, Malhotra R, Liotta L, Doxsey SJ . Centrosome defects can account for cellular and genetic changes that characterize prostate cancer progression. Cancer Res 2001; 61: 2212–2219.
  CAS PubMed Google Scholar
• Schneeweiss A, Sinn HP, Ehemann V, Khbeis T, Neben K, Krause U et al. Centrosomal aberrations in primary invasive breast cancer are associated with nodal status and hormone receptor expression. Int J Cancer 2003; 107: 346–352.
  Article CAS Google Scholar
• Krämer A, Schweizer S, Neben K, Giesecke C, Kalla J, Katzenberger T et al. Centrosome aberrations as a possible mechanism for chromosomal instability in non-Hodgkin's lymphoma. Leukemia 2003; 17: 2207–2213.
  Article Google Scholar
• Bornens M . Centrosome composition and microtubule anchoring mechanisms. Curr Opin Cell Biol 2002; 14: 25–34.
  Article CAS Google Scholar
• Andersen JS, Wilkinson CJ, Mayor T, Mortensen P, Nigg EA, Mann M . Proteomic characterization of the human centrosome by protein correlation profiling. Nature 2003; 426: 570–574.
  Article CAS Google Scholar
• Löffler H, Lukas J, Bartek J, Krämer A . Structure meets function – centrosomes, genome maintenance and the DNA damage response. Exp Cell Res 2006; 312: 2633–2640.
  Article Google Scholar
• Doxsey S, McCollum D, Theurkauf W . Centrosomes in cellular regulation. Annu Rev Cell Dev Biol 2005; 21: 411–434.
  Article CAS Google Scholar
• Nigg EA . Mitotic kinases as regulators of cell division and its checkpoints. Nat Rev Mol Cell Biol 2001; 2: 21–32.
  Article CAS Google Scholar
• Krämer A, Lukas J, Bartek J . Checking out the centrosome. Cell Cycle 2004; 3: 1390–1393.
  Article Google Scholar
• Giehl M, Fabarius A, Frank O, Hochhaus A, Hafner M, Hehlmann R et al. Centrosome aberrations in chronic myeloid leukemia correlate with stage of disease and chromosomal instability. Leukemia 2005; 19: 1192–1197.
  Article CAS Google Scholar
• Fabarius A, Giehl M, Frank O, Duesberg P, Hochhaus A, Hehlmann R et al. Induction of centrosome and chromosome aberrations by imatinib in vitro. Leukemia 2005; 19: 1573–1578.
  Article CAS Google Scholar
• Hakansson P, Lassen C, Olofsson T, Baldetorp B, Karlsson A, Gullberg U et al. Establishment and phenotypic characterization of human U937 cells with inducible p210 BCR/ABL expression reveals upregulation of CEACAM1 (CD66a). Leukemia 2004; 18: 538–547.
  Article CAS Google Scholar
• Shaffer LG, Tommerup N (eds). . ISCN 2005, An International System for Human Cytogenetic Nomenclature. S Karger: Basel, 2005, pp 6–120.
  Google Scholar
• Schoch C, Schnittger S, Bursch S, Gerstner D, Hochhaus A, Berger U et al. Comparison of chromosome banding analysis, interphase- and hypermetaphase-FISH, qualitative and quantitative PCR for diagnosis and for follow-up in chronic myeloid leukemia: a study on 350 cases. Leukemia 2002; 16: 53–59.
  Article CAS Google Scholar
• Wang YL, Lee JW, Cesarman E, Jin DK, Csernus B . Molecular monitoring of chronic myelogenous leukemia: identification of the most suitable internal control gene for real-time quantification of BCR-ABL transcripts. J Mol Diagn 2006; 8: 231–239.
  Article CAS Google Scholar
• Singer CF, Hudelist G, Lamm W, Mueller R, Handl C, Kubista E et al. Active (p)CrkL is overexpressed in human malignancies: potential role as a surrogate parameter for therapeutic tyrosine kinase inhibition. Oncol Rep 2006; 15: 353–359.
  CAS PubMed Google Scholar
• Barnes DJ, Schultheis B, Adedeji S, Melo JV . Dose-dependent effects of Bcr-Abl in cell line models of different stages of chronic myeloid leukemia. Oncogene 2005; 24: 6432–6440.
  Article CAS Google Scholar
• Barnes DJ, Palaiologou D, Panousopoulou E, Schultheis B, Yong AS, Wong A et al. Bcr-Abl expression levels determine the rate of development of resistance to imatinib mesylate in chronic myeloid leukemia. Cancer Res 2005; 65: 8912–8919.
  Article CAS Google Scholar
• Fossey SC, Ferreira-Gonzalez A, Garrett CT, Dumur CI, Vnencak-Jones CL . BCRABL transcript detection by quantitative real-time PCR: are correlated results possible from homebrew assays? Mol Diagn 2005; 9: 187–193.
  PubMed Google Scholar
• Cortes J, O’Dwyer ME . Clonal evolution in chronic myelogenous leukemia. Hematol Oncol Clin North Am 2004; 18: 671–684.
  Article Google Scholar
• Amiel A, Yukla M, Gaber E, Leopold L, Josef G, Fejgin M et al. Random aneuploidy in CML patients at diagnosis and under imatinib treatment. Cancer Genet Cytogenet 2006; 168: 120–123.
  Article CAS Google Scholar
• Parvin JD, Sankaran S . The BRCA1 E3 ubiquitin ligase controls centrosome dynamics. Cell Cycle 2006; 5: 1946–1950.
  Article CAS Google Scholar
• Sankaran S, Parvin JD . Centrosome function in normal and tumor cells. J Cell Biochem 2006; 99: 1240–1250.
  Article CAS Google Scholar
• Ko MJ, Murata K, Hwang D-S, Parvin JD . Inhibition of BRCA1 in breast cell lines causes the centrosome duplication cycle to be disconnected from the cell cycle. Oncogene 2006; 25: 298–303.
  Article CAS Google Scholar
• Foray N, Marot D, Randrianarison V, Venezia ND, Picard D, Perricaudet M et al. Constitutive association of BRCA1 and c-Abl and its ATM-dependent disruption after irradiation. Mol Cell Biol 2002; 22: 4020–4032.
  Article CAS Google Scholar
• Deutsch E, Jarrousse S, Buet D, Dugray A, Bonnet ML, Vozenin-Brotons MC et al. Down-regulation of BRCA1 in BCR-ABL-expressing hematopoietic cells. Blood 2003; 101: 4583–4588.
  Article CAS Google Scholar